Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Split-hand Index in CMAP Types of Amyotrophic Lateral Sclerosis

View through CrossRef
Background: Split hand is an early clinical sign in amyotrophic lateral sclerosis (ALS) where thenar muscles are substantially more involved than that of hypothenar muscle and Split-hand Index (SI) is the electrophysiological measurement of it. Objective: Ourobjective was to assess the utility of Split-hand Index in Amyotrophic lateral sclerosis (ALS). Methods: Total 56 study subjects, 28 ALS patients and 28 age & sex matched healthy controls (HCs) were enrolled after satisfying the selection criteria. According to El Escorial diagnostic criteria ALS patients were recruited. Severity and muscle strength state were assessed by ALS functional rating scale-revised (ALSFRS-R) and Medical Research Council (MRC) scores respectively. Then electrophysiology was done to measure SI both in ALS patients and HCs by compound muscle action potential (CMAP) based method. SI was evaluated according to CMAP types in ALS (normal CMAP and reduced CMAP). Collected data were analyzed by IBM SPSS (Statistical Package for Social Sciences) version 26 to observe relation of SI with ALS and its utility. Results: SI was reduced significantly both in normal CMAP and reduced CMAP ALS than Healthy controls (SIReduced CMAP – 1.83±1.30, SINormal CMAP – 5.59±3.72 and SIHCs – 10.57±3.72; p<0.001). SI was positively correlated (r = +0.769, p<0.001) with severity status (ALSFRS-R). SI was also significantly correlated (r= +.893, p<0.001) with status of muscle strength (according to MRC score). Receiver operating characteristic (ROC) curve analysis showed that SI reliably differentiated ALS patients from healthy controls with a cut-off value 5.04 exhibiting 82.1% sensitivity and 85.7% specificity. Conclusion: SI was significantly related with normal CMAP and reduced CMAPALS and reliably differentiated from HCs with high diagnostic accuracy. SI also had strong positive correlation with severity and muscle strength state signifying its role in diagnosis and monitoring ofALS.
Title: Split-hand Index in CMAP Types of Amyotrophic Lateral Sclerosis
Description:
Background: Split hand is an early clinical sign in amyotrophic lateral sclerosis (ALS) where thenar muscles are substantially more involved than that of hypothenar muscle and Split-hand Index (SI) is the electrophysiological measurement of it.
Objective: Ourobjective was to assess the utility of Split-hand Index in Amyotrophic lateral sclerosis (ALS).
Methods: Total 56 study subjects, 28 ALS patients and 28 age & sex matched healthy controls (HCs) were enrolled after satisfying the selection criteria.
According to El Escorial diagnostic criteria ALS patients were recruited.
Severity and muscle strength state were assessed by ALS functional rating scale-revised (ALSFRS-R) and Medical Research Council (MRC) scores respectively.
Then electrophysiology was done to measure SI both in ALS patients and HCs by compound muscle action potential (CMAP) based method.
SI was evaluated according to CMAP types in ALS (normal CMAP and reduced CMAP).
Collected data were analyzed by IBM SPSS (Statistical Package for Social Sciences) version 26 to observe relation of SI with ALS and its utility.
Results: SI was reduced significantly both in normal CMAP and reduced CMAP ALS than Healthy controls (SIReduced CMAP – 1.
83±1.
30, SINormal CMAP – 5.
59±3.
72 and SIHCs – 10.
57±3.
72; p<0.
001).
SI was positively correlated (r = +0.
769, p<0.
001) with severity status (ALSFRS-R).
SI was also significantly correlated (r= +.
893, p<0.
001) with status of muscle strength (according to MRC score).
Receiver operating characteristic (ROC) curve analysis showed that SI reliably differentiated ALS patients from healthy controls with a cut-off value 5.
04 exhibiting 82.
1% sensitivity and 85.
7% specificity.
Conclusion: SI was significantly related with normal CMAP and reduced CMAPALS and reliably differentiated from HCs with high diagnostic accuracy.
SI also had strong positive correlation with severity and muscle strength state signifying its role in diagnosis and monitoring ofALS.

Related Results

Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Abstract Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognit...
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Abstract Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease that targets motor neurons in the cerebral cortex, medulla oblongata, ...
Genetic aspects of amyotrophic lateral sclerosis
Genetic aspects of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a progressive, incurable neurodegenerative disease characterized by motor neuron loss and the development of paralysis and skeletal muscle atrophy....
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
INTRODUCTION. Despite the fact that more than 150 years have passed since the first mention of amyotrophic lateral sclerosis (ALS), the issues of etiology, pathogenesis, diagnosis ...
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...

Back to Top